Patients' knowledge and experience of adjuvant endocrine therapy for early breast cancer: A European study

Breast

Volumn 16, Issue 5, 2007, Pages 462-468

  Wengström, Yvonne ^a   Aapro, Matti ^b   Leto di Priolo, Susanna ^c   Cannon, Helena ^d   Georgiou, Vasoulla ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CLINIQUE DE GENOLIER   (Switzerland)

^c Respiratory Clinical Research   (Italy)

^d ADELPHI REAL WORLD   (United Kingdom)

Author keywords

Adjuvant endocrine therapy; Decision making; Early breast cancer; Information needs; Post menopausal; Recurrence risk

Indexed keywords

ANASTROZOLE; EXEMESTANE; LETROZOLE; TAMOXIFEN;

ACCESS TO INFORMATION; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; CONTROLLED STUDY; EARLY CANCER; EDUCATION; EUROPE; FEMALE; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PATIENT ATTITUDE; PATIENT EDUCATION; PERSONAL EXPERIENCE; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENCE RISK; WOMEN'S RIGHTS;

EID: 34848830716     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.02.007     Document Type: Article

References (27)

1. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005) 1687-1717
2. Chia S., Speers C.H., Bryce C.J., Hayes M., and Olivotto I. Ten-year outcomes in a population-based cohort of node-negative, lymphatic and vascular invasion-negative early breast cancers without adjuvant systemic therapies. J Clin Oncol 22 (2004) 1630-1637
3. Fisher B., Jeong J.-H., Bryant J., Anderson S., Dignam J., and Wolmark N. Treatment of lymph-node-negative, estrogen receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Lancet 364 (2004) 858-868
4. Fisher B., Dignam J., Bryant J., et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 88 (1996) 1529-1542
5. The Breast International Group (BIG) 1-98 Collaborative Group. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Eng J Med 353 (2005) 2747-2757
6. Howell A., Cuzick J., Baum M., et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365 (2005) 60-62
7. Coombes R.C., Hall E., Gibson L.J., et al. Intergroup exemestane study. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med. 350 (2004) 1081-1092
8. Goss P.E., Ingle J.N., Martino S., et al. Randomised trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst 97 (2005) 1262-1271
9. Degner L.F., Kristjanson L.J., Bowman D., et al. Information needs and decisional preferences in women with breast cancer. JAMA 277 (1997) 1485-1492
10. Keating K.L., Guadagnoli E., Landrum M.B., Borbas C., and Weeks J.C. Treatment decision making in early stage breast cancer: should surgeons match patients' desired level of involvement?. J Clin Oncol 20 (2002) 1473-1479
11. Street R.L., and Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decis Making 17 (1997) 298-306
12. Mandelblatt J., Kreling B., Figeuriedo M., and Feng S. What is the impact of shared decision making and outcomes for older women with breast cancer?. J Clin Oncol 30 (2006) 4908-4913
13. Thind A., and Maly R. The surgeon-patient interaction in older women with breast cancer: what are the determinants of a helpful discussion?. Ann Surg Oncol 13 (2006) 788-793
14. Thomas R., Godward S., Makris A., Bloomfield D., Moody A.M., and Williams M. Giving patients a choice improves quality of life: a multi-centre, investigator-blind, randomised crossover study comparing letrozole with anatrozole. Clin Oncol (R Coll Radiol) 16 (2004) 485-491
15. Fallowfield L., Atkins L., et al. Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Ann Oncol 17 (2006) 205-210
16. Partridge A.H., Wang P.S., Winer E.P., and Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21 (2003) 602-606
17. Atkins L., and Fallowfield L. Intentional and non-intentional non-adherence to medication amongst breast cancer patients. Eur J Cancer 42 (2006) 2271-2276
18. Ravdin P.M., Siminoff I.A., Davis G.J., et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19 (2001) 980-981
19. Whelan T., Sawka C., Levine M., et al. Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst 95 (2003) 581-587
20. Levine M., and Whelan T. Decision-making process-communicating risk/benefits: is there an ideal technique?. J Natl Cancer Inst Monogr 30 (2001) 143-145
21. Thewes B., Meiser B., Taylor A., et al. The fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23 (2005) 5155-5165
22. Veronesi U., von Kleist S., Redmond K., et al. Caring about Women and Cancer (CAWAC): a European survey of the perspectives and experiences of women with female cancers. Eur J Cancer 35 (1999) 1667-1675
23. McGurk R., Fallowfield L., and Winters Z. Information provision for patients by breast cancer teams about the side-effects of hormone treatments. Eur J Cancer 42 (2006) 1760-1767
24. Leighl N., Gattellari M., Butow P., Brown R., and Tattersall M.H.N. Discussing adjuvant therapy. J Clin Oncol 19 (2001) 1768-1778
25. Ong L.M.L., Visser M.R.M., Lammes F.B., vam der Velden B.C., Kuenen B.C., and de Haes J.C.J.M. Effect of providing cancer patients with the audiotaped initial consultation on satisfaction, recall, and quality of life: a randomized, double-blind study. J Clin Oncol 18 (2000) 3052-3060
26. Ravdin P.M., Siminoff I.A., and Harvey J.A. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 16 (1998) 515-521
27. Lobb E.A., Butow P.N., Kenny D.T., and Tattersall M.H. Communicating prognosis in early breast cancer: do women understand the language used. Med J Aust 171 (1999) 290-294